Fiduciary Trust CO Ionis Pharmaceuticals Inc Transaction History

Fiduciary Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $172,575 - $228,949	-3,637 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $170,393 - $222,038	3,637 New	3,637 $214,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $151,299 - $230,585	-3,637 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$53.85 - $65.27 $1,077 - $1,305	-20 Reduced 0.55%	3,637 $220,000
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $10,040 - $12,265	-170 Reduced 4.44%	3,657 $219,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $21,731 - $30,149	-350 Reduced 8.38%	3,827 $246,000
Q4 2018 Jan 29, 2019	SELL	$43.37 - $59.54 $4,597 - $6,311	-106 Reduced 2.47%	4,177 $226,000
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $183,655 - $229,997	4,283 New	4,283 $220,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Trust CO with notifications on news.